Pure Global

Toe Walker Gait Trial - Trial NCT01208142

Access comprehensive clinical trial information for NCT01208142 through Pure Global AI's free database. This phase not specified trial is sponsored by Dynasplint Systems, Inc. and is currently Terminated. The study focuses on Gait. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT01208142
Terminated
other
Trial Details
ClinicalTrials.gov โ€ข NCT01208142
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Toe Walker Gait Trial
Dynamic Splinting for Toe Walking: a Randomized, Controlled Study With Gait Analysis

Study Focus

Gait

standard of care treatment

Interventional

other

Sponsor & Location

Dynasplint Systems, Inc.

Columbus,Lubbock, United States of America

Timeline & Enrollment

N/A

Sep 01, 2010

N/A

10 participants

Primary Outcome

Change in plantar flexion while ambulating

Summary

The purpose of this study is to examine the change in ankle plantar flexion while walking,
 following treatment with the Ankle Dorsiflexion Dynasplint (AFD) for children diagnosed as
 Toe Walkers.
 
 For twelve weeks, patients will either receive the standard treatment or the same standard
 treatment and the Dynaslint worn at night.

ICD-10 Classifications

Paralytic gait
Abnormalities of gait and mobility
Other and unspecified abnormalities of gait and mobility
Ataxic gait
Fall on and from stairs and steps

Data Source

ClinicalTrials.gov

NCT01208142

Non-Device Trial